Cardiovascular Diseases
The study evaluates asundexian against apixaban to reduce risk of stroke in patients with atrial fibrillation, aiming to improve prevention of stroke or systemic embolism.
- Comparison of novel anticoagulant with standard therapy
- Assessment of major bleeding risk
- Evaluation of overall benefit‑risk profile
Health Step Finland Oy conducts this cardiovascular research at its Kuopio facility, contributing to safer anticoagulation options.
Nutritional and Metabolic Diseases
The trial investigates whether survodutide added to a reduced‑calorie diet and increased physical activity can produce greater weight loss in adults with obesity, focusing on efficacy and safety.
- Weight reduction efficacy
- Safety and tolerability assessment
- Impact on weight‑related complications
Conducted in Kuopio, Finland, this research by Health Step Finland Oy explores new therapeutic options for managing obesity without diabetes.
